ASCENDIS HEALTH LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8 ZAR | 0.00% |
|
0.00% | +2.56% |
| Mar. 29 | Ascendis Health Seeks Acquisitions | CI |
| Mar. 28 | Ascendis Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 5,322 | 2,282 | 407.3 | 280.4 | 328.7 | 412.1 |
| Enterprise Value (EV) 1 | 10,257 | 7,632 | 7,233 | 6,893 | 753.1 | 357 |
| P/E ratio | 18.2 x | -0.49 x | -0.4 x | -0.26 x | 0.73 x | 5.31 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.69 x | 0.41 x | 0.06 x | 0.13 x | 0.21 x | 0.27 x |
| EV / Revenue | 1.33 x | 1.37 x | 1.04 x | 3.09 x | 0.48 x | 0.23 x |
| EV / EBITDA | 8.19 x | 54.4 x | 7.45 x | -168 x | -35.2 x | -4.11 x |
| EV / FCF | -65.7 x | -2.25 x | -7.84 x | -1.48 x | 0.13 x | -9.22 x |
| FCF Yield | -1.52% | -44.4% | -12.8% | -67.6% | 766% | -10.8% |
| Price to Book | 0.8 x | 1.16 x | 0.34 x | 0.81 x | 0.81 x | 0.73 x |
| Nbr of stocks (in thousands) | 488,298 | 485,499 | 484,827 | 483,494 | 483,452 | 624,379 |
| Reference price 2 | 10.90 | 4.700 | 0.8400 | 0.5800 | 0.6800 | 0.6600 |
| Announcement Date | 9/21/18 | 10/31/19 | 9/30/20 | 9/30/21 | 9/27/22 | 9/29/23 |
1ZAR in Million2ZAR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 7,737 | 5,574 | 6,963 | 2,229 | 1,559 | 1,535 |
| EBITDA 1 | 1,252 | 140.4 | 971.3 | -41.04 | -21.4 | -86.9 |
| EBIT 1 | 933.7 | -80.41 | 589.9 | -101.1 | -67.38 | -145.1 |
| Operating Margin | 12.07% | -1.44% | 8.47% | -4.53% | -4.32% | -9.45% |
| Earnings before Tax (EBT) 1 | 564 | -4,632 | -959.1 | -1,531 | -795.4 | -284.6 |
| Net income 1 | 277.2 | -4,670 | -1,001 | -1,091 | 449.2 | 75.32 |
| Net margin | 3.58% | -83.78% | -14.37% | -48.94% | 28.8% | 4.91% |
| EPS 2 | 0.5999 | -9.633 | -2.096 | -2.265 | 0.9312 | 0.1242 |
| Free Cash Flow 1 | -156.2 | -3,386 | -922.3 | -4,661 | 5,766 | -38.71 |
| FCF margin | -2.02% | -60.75% | -13.24% | -209.1% | 369.73% | -2.52% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | 1,283.57% | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/21/18 | 10/31/19 | 9/30/20 | 9/30/21 | 9/27/22 | 9/29/23 |
1ZAR in Million2ZAR
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 4,934 | 5,350 | 6,826 | 6,613 | 424 | - |
| Net Cash position 1 | - | - | - | - | - | 55.1 |
| Leverage (Debt/EBITDA) | 3.942 x | 38.11 x | 7.027 x | -161.1 x | -19.83 x | - |
| Free Cash Flow 1 | -156 | -3,386 | -922 | -4,661 | 5,766 | -38.7 |
| ROE (net income / shareholders' equity) | 8.2% | -107% | -54.7% | -167% | -166% | -59.3% |
| ROA (Net income/ Total Assets) | 3.84% | -0.37% | 3.13% | -0.55% | -0.68% | -6.85% |
| Assets 1 | 7,225 | 1,263,633 | -31,932 | 197,538 | -65,673 | -1,100 |
| Book Value Per Share 2 | 13.70 | 4.050 | 2.490 | 0.7200 | 0.8300 | 0.9000 |
| Cash Flow per Share 2 | 1.580 | 0.6000 | 0.8200 | 0.7600 | 0.4400 | 0.1600 |
| Capex 1 | 255 | 262 | 213 | 39.2 | 55.5 | 35.7 |
| Capex / Sales | 3.3% | 4.71% | 3.05% | 1.76% | 3.56% | 2.33% |
| Announcement Date | 9/21/18 | 10/31/19 | 9/30/20 | 9/30/21 | 9/27/22 | 9/29/23 |
1ZAR in Million2ZAR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +2.56% | 26.6M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- ASC Stock
- Financials Ascendis Health Limited
